EVOKAI CREATIVE LABS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.085 CAD | -.--% |
|
-34.62% | +13.33% |
| Sales 2022 | - | Sales 2023 | - | Capitalization | 4.3M 5.86M |
|---|---|---|---|---|---|
| Net income 2022 | - 0 | Net income 2023 | -17M -23.16M | EV / Sales 2022 * | - |
| Net Debt 2022 | 41.46K 56.49K | Net Debt 2023 | 12.58K 17.14K | EV / Sales 2023 | - |
| P/E ratio 2022 * |
-
| P/E ratio 2023 |
-0.22
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 41.51% |
More Fundamentals
* Assessed data
More news
| 1 week | -34.62% | ||
| 1 month | -34.62% | ||
| 3 months | -15.00% | ||
| 6 months | -91.50% | ||
| Current year | +13.33% |
1 week
0.09
0.09
1 month
0.090.09
Current year
0.080.15
1 year
0.082.15
3 years
0.082.15
5 years
0.082.15
10 years
0.082.15
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
Scott Ackerman
DFI | Director of Finance/CFO | 57 | - |
Rauno Jokelainen
COO | Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Scott Ackerman
DFI | Director of Finance/CFO | 57 | - |
Peter E. Dickie
BRD | Director/Board Member | 61 | - |
Rick Cox
BRD | Director/Board Member | 63 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-30 | 0.085 | -.--% | 10,000 |
| 24-05-29 | 0.085 | -.--% | 3,000 |
Delayed Quote Toronto S.E., May 30, 2024 at 11:45 am EDT
More quotes
EvokAI Creative Labs Inc. is a MedTech artificial-intelligence-powered company. It is engaged in the development of transformational technologies for the modern health care sector. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. It offers its AI algorithms across the whole health care system, from hospitals, private clinics, research institutions, pharmaceutical companies, contract research organizations to medical professionals, patients, and healthy individuals, aiming at preventing and early detecting any kind of disease and protecting the aging genome. Its divisions include EvokAI Simulators, EvokAI Sensors, EvokAI Neurotrainer and EvokAI Medical. EvokAI Simulators combines cognitive neuroscience, virtual reality and artificial intelligence technologies to assess cognitive performance and spatial perception.
| 1st Jan change | Capi. | |
|---|---|---|
| +13.33% | 4.74M | |
| -9.49% | 28.16B | |
| +25.35% | 8.33B | |
| +33.25% | 4.39B | |
| -35.85% | 2.43B | |
| -9.44% | 1.6B | |
| -13.39% | 1.5B | |
| -32.84% | 1.15B | |
| +7.80% | 964M | |
| -37.56% | 872M |
- Stock Market
- Equities
- OKAI Stock
